EAM Investors’s Acutus Medical Inc AFIB Stock Holding History

EAM Investors’s Portfolio AFIB Stock Details AFIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-33,120	Closed	-$987K	–	409
2020 Q3	$987K	Buy	+33,120	New	+$1.01M	0.23%	208

Other funds holding AFIB

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AFG

American Financial Group Cincinnati, Ohio $284M AUM 12.01% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

PVI

Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return

EAM Investors's AFIB Position: Q4 2020 in Review

EAM Investors sold out of Acutus Medical Inc (AFIB) in Q4 2020, closing a stake of 33,120 shares — an estimated $987K sold.

EAM Investors first reported a position in AFIB in Q3 2020 and held it in 1 quarter. The position peaked at $987K in Q3 2020. 65 funds tracked by Wall St. Rank hold AFIB as of Q4 2020.

EAM Investors reported no remaining Acutus Medical Inc position as of Q4 2020 after selling out during the quarter.
EAM Investors sold 33,120 Acutus Medical Inc shares in Q4 2020, an estimated $987K.
EAM Investors first reported a position in Acutus Medical Inc in Q3 2020 and held it in 1 quarter.
EAM Investors's Acutus Medical Inc position peaked at $987K in Q3 2020.
65 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q4 2020.

Based on EAM Investors's 13F filing for Q4 2020, filed 11 Feb 2021.